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Post-transcriptional regulation of gene expression by RNA-binding proteins and by small non-
coding RNAs plays an important role in cell biology. Our previous results show that in murine
skeletal myoblasts, the expression of Pinch-2, a focal adhesion remodeling factor that regulates cell
motility, is repressed by an RNA-binding protein IMP-2/Igf2bp2. We now show that the expression of
Pinch-2 is also regulated by the miRNA let-7g. Let-7g and IMP-2 repress Pinch-2 expression indepen-
dently of each other. A knock-down of let-7g leads to an increase in Pinch-2 expression, and to a
decrease of cell motility, which can be reversed by a simultaneous knock-down of Pinch-2. We con-
clude that let-7g controls the motility of mouse myoblasts in cell culture by post-transcriptionally
regulating the expression of Pinch-2.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Post-transcriptional regulation of gene expression depends on
multiple and complex mechanisms that ﬁne-tune the levels of pro-
tein synthesis from speciﬁc mRNA transcripts. The main regulatory
factors of post-transcriptional regulation are various RNA-binding
proteins, as well as small non-coding RNAs, such as microRNAs
(miRNAs). Some of the best-characterized examples of such regula-
tion by RNA-binding proteins include the studies of the IMP/
Igf2bp1-3 (Insulin-Like Growth Factor 2 mRNA-binding proteins
1, 2, and 3) family and its mRNA targets [1], reviewed in [2]. Thus,
IMP-1/ZBP-1 (zipcode-binding protein 1) binds to a group of
mRNAs coding for key regulatory factors for cellular motility and
adhesion (b-actin, the Arp2/3 complex, alpha-actinin, E-cadherin)
[3]. The functions of IMP-1 in human cancer cells include stabiliza-
tion of focal adhesions and maintenance of the cellular capacity for
directional motility [4]. Other studies have also shown a link
between cellular motility, cellular adhesion, and the expression
of members of IMP family [5].Focal adhesions (FAs) are large protein complexes that directly
regulate cell anchorage and cell motility, and also have an
important impact on cell proliferation, stress response and signal
transduction (reviewed in [6]). These structures are highly
dynamic and can rapidly disassemble and reassemble following
an interaction with numerous FA regulatory proteins. Pinch-2 pro-
tein can interact with the FAs and induce their remodeling in
human and mouse cells, and an overexpression of Pinch-2 leads
to dramatic changes in cell spreading and cell motility [7,8]. Thus,
the expression levels of Pinch-2 have to be regulated by the cell in
order to ensure a normal functioning. The migration capacity of
myoblasts is particularly important in skeletal muscle develop-
ment and maintenance, where the cells frequently have to undergo
directed, long-range migration in order to form new muscle, or to
regenerate the damaged muscle tissue (reviewed in [9]). We have
earlier shown that the expression of Pinch-2 is very efﬁciently
regulated at the post-transcriptional level by an RNA-binding
protein IMP-2/Igf2bp2 in mouse and human muscle cells [10]. In
the current study, we are describing another post-transcriptional
regulatory mechanism that controls Pinch-2 expression in mouse
myoblasts.
We now show that the expression of Pinch-2 depends on
Argonaute 2 (Ago-2), a key regulatory protein in RNA interference
(RNAi), indicating that Pinch-2 mRNA can be a target of RNAi in
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Fig. 1. Expression of Pinch-2 in mouse myoblasts is suppressed by Ago-2 protein.
(A) Pinch-2 mRNA levels were quantiﬁed by RT-qPCR in C2C12 myoblasts
transfected with the indicated siRNAs and collected 48 h post-transfection. Control:
Cyclophilin A. (B) Western blot showing the protein levels of Ago-2, Pinch-2 and b-
actin in cells described in A. Ago-2. 1–3 stand for three distinct siRNAs against Ago-
2. We have subsequently studied the expression of endogenous let-7g in C2C12
myoblasts (Fig. 2D), and have demonstrated that inhibition of let-7g expression by
antisense LNA (Locked Nucleic Acid) inhibitors was very efﬁcient (Fig. 2E). A
decrease of let-7g dramatically increased the levels of endogenous Pinch-2 mRNA
and protein (Fig. 2F and G). As a positive control for the efﬁciency of let-7 inhibition,
we have monitored two well-known let-7 targets, IGF2BP1 and HMGA2 (14). In a
complementary gain-of-function assay, transfection of mimic let-7g molecules led
to a slight, but highly reproducible inhibition of Pinch-2 expression (Fig. 2H). The
slight effect of ectopic let-7g on endogenous Pinch-2 is hardly surprising, given the
abundance and variety of endogenous let-7 miRNAs.
1624 S. Boudoukha et al. / FEBS Letters 588 (2014) 1623–1629mouse myoblasts. Indeed, we ﬁnd that in addition to IMP-2, the
expression of Pinch-2 is repressed by the microRNA (miRNA)
let-7g-5p (further referred to as let-7g). Let-7g belongs to one of
the most widely and abundantly expressed, conserved, and func-
tionally important miRNA families known to date (reviewed in
[11,12]). In human, this family consists of ten highly similar miR-
NAs (let-7a to i, miR-98 and miR-202) that share the same seed
sequence, and in most cases were shown to target the same mRNAs
and to have redundant functions (reviewed in [11]).
We show that the 30UTR of Pinch-2 mRNA has four functionally
important sites for let-7g. A knock-down (KD) of let-7g or of IMP-2
signiﬁcantly increased Pinch-2 mRNA and protein levels, and a
simultaneous KD of let-7g and IMP-2 led to an additional increase
of Pinch-2, suggesting that the repression by IMP-2 and let-7g
occurs by two independent mechanisms. Finally, we show that
let-7g is important for the motility of mouse myoblasts, and that
this function of let-7g depends on Pinch-2 expression levels.
2. Results
2.1. Expression of Pinch-2 in mouse myoblasts is suppressed by Ago-2
protein
To characterize the mechanisms of Pinch-2 post-transcriptional
regulation in mouse myoblasts C2C12, we have decreased the
expression of key RNAi regulatory protein Ago-2 by three different
siRNAs and analyzed the expression of Pinch-2 mRNA and protein.
In mammalian cells, Ago-2 is known to be recruited to the target
mRNAs by speciﬁc short non-coding RNAs (microRNAs, or miR-
NAs). Subsequently, miRNA-recruited Ago-2 containing complexes
can induce translational repression and/or degradation of the
target mRNAs (reviewed in [13]).
The results of RT-qPCR and Western blot assays in C2C12 myo-
blasts depleted of Ago-2 show an up-regulation of endogenous
Pinch-2 mRNA and protein in Ago-2 depleted cells (Fig. 1A and
B). We concluded that Pinch-2 can be a target of miRNA regulation
in mouse myoblasts.
2.2. Pinch-2 expression is directly regulated by the miRNA let-7
We have analyzed the 30UTR of PINCH-2 using the software
available at http://genie.weizmann.ac.il/pubs/mir07/mir07_pre-
diction.html, and identiﬁed a number of potential miRNA-binding
sites. Among these predictions, we were interested in four poten-
tial let-7 binding sites at positions 28, 67, 189, and 205 (Fig. 2A).
Let-7 miRNA family is widely expressed, conserved and very well
studied, and the best characterized let-7 targets are known to pos-
sess multiple let-7 sites in their 30-UTRs [14]. In order to study the
effect of let-7 on the expression of Pinch-2, we have cloned the
30UTR of Pinch-2 into the luciferase reporter construct psiCheck2.
The expression of the Renilla luciferase in this construct is regu-
lated by the 30UTR of interest, whereas the Fireﬂy luciferase serves
as an internal control of the transfection efﬁciency. Co-transfection
of the psiCheck2-Pinch-2 construct with let-7g or control miRNAs
showed that the 30UTR of Pinch-2 is strongly and speciﬁcally
regulated by let-7g miRNA (Fig. 2B). In addition to an irrelevant
negative control miRNA, we have included in our experiments
miR-193b, a miRNA that is expressed in myoblasts, but is not
predicted to target Pinch-2. Site-directed mutagenesis of let-7 sites
in the 30UTR of Pinch-2 showed that all four sites are necessary for
this repression, because their individual inactivation did not signif-
icantly release the let-7 dependent repression (Fig. 2C).
We have studied the expression of endogenous let-7g in C2C12
myoblasts, which was found to be relatively stable in proliferating
or in differentiating cells (Fig. 2D). Subsequently, we have demon-
strated that inhibition of let-7g expression by antisense LNA(Locked Nucleic Acid) inhibitors was very efﬁcient (Fig. 2E). A
decrease of let-7g dramatically increased the levels of endogenous
Pinch-2 mRNA and protein (Fig. 2F and G). As a positive control for
the efﬁciency of let-7 inhibition, we have monitored two
well-known let-7 targets, IGF2BP1 and HMGA2 [14]. In a comple-
mentary gain-of-function assay, transfection of let-7g mimic led
to a slight, but highly reproducible inhibition of Pinch-2 expression
(Fig. 2H). The slight effect of ectopic let-7g on endogenous Pinch-2
is hardly surprising, given the abundance and variety of endoge-
nous let-7 miRNAs.
2.3. Let-7 and IMP-2 act independently to suppress the expression
of Pinch-2
In our previous work, we have shown that Pinch-2 expression is
down-regulated in C2C12 cells by the RNA-binding protein IMP-2,
which interacts with the 30UTR of Pinch-2 mRNA [10]. We have
studied the regulation of endogenous Pinch-2 mRNA and protein
by let-7g and IMP-2 by co-transfecting let-7g antisense inhibitor
and/or two different siRNAs directed against IMP-2. In agreement
with previous results, individual inhibition of let-7g or IMP-2 par-
tially released the repression of Pinch-2 in C2C12 cells. A simulta-
neous inhibition of IMP-2 and let-7g led to a dramatic
de-repression of Pinch-2 mRNA and protein (Fig. 3A and B). The
de-repression obtained by a KD of let-7g and IMP-2 together was
more important than the sum of the effects obtained by individual
KDs of let-7g or of IMP-2. These results indicate that let-7g and
IMP-2 repression factors can act independently on Pinch-2 30UTR,
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Fig. 2. Pinch-2 expression is directly regulated by the miRNA let-7. (A) A schema of the 30UTR of mouse Pinch-2 with the potential target sites of let-7 miRNA shown in grey,
numbers (28, 67, 189, 205) correspond to the positions of the ﬁrst nucleotide of each target site, starting from the beginning of the 30UTR. Let7: alignment with the seed
sequence of let-7 family. Mut: mutations to potential let-7 target sites. (B) The 30UTR of Pinch-2 was cloned into the pSiCheck.2 reporter vector after the reporter gene (Renilla
luciferase) and the relative levels of Renilla versus Fireﬂy luciferase (the latter serving as a control of the transfection efﬁciency) were measured in C2C12 cells co-transfected
with the indicated miRNA precursors, 24 h post-transfection. (C) The potential let-7 target sites in the 30UTR of pSiCheck.2-Pinch-2 were mutated individually or together, as
indicated. Shown are the relative levels of Renilla versus Fireﬂy luciferase measured in C2C12 cells co-transfected with control of let-7g miRNA precursors, 24 h post-
transfection. (D) The expression of endogenous let-7g in C2C12 myoblasts in proliferation and differentiation was evaluated by RT-qPCR in three independent experiments
(biological triplicate). (E) The efﬁciency of let-7g inhibition by LNA antisense inhibitor was evaluated by RT-qPCR. (F, G) The levels of endogenous Pinch-2 mRNA (F) and
protein (G) were studied in C2C12 cells transfected with the indicated miRNA inhibitors and collected 48 h later. The levels of known let-7 targets IGF2BP1 and HMGA2 are
monitored in (G) to evaluate the efﬁciency and speciﬁcity of let-7 inhibitor. (H) The levels of endogenous Pinch-2 protein in C2C12 cells transfected with the indicated miRNA
mimics and collected 48 h later.
S. Boudoukha et al. / FEBS Letters 588 (2014) 1623–1629 1625and that their simultaneous absence can have a synergistic positive
effect on the expression of Pinch-2, probably by facilitating a
recruitment of supplementary RNA-binding factors.
Consistent with these observations, inhibition of let-7g or of
another let-7 family member, miR-98, in C2C12 myoblasts led to
a remodeling of focal adhesions (FAs), similar to what can be
observed in IMP-2 knock-down cells. FAs, here stained with vincu-
lin or phospho-tyrosine antibody, appear as small individual struc-
tures in control cells, and have a strong tendency to cluster and/or
fuse together in cells with inhibited let-7g/miR-98 or IMP-2(Fig. 3C and D). This effect is consistent with what was previously
observed in Pinch-2 overexpressing cells [10].
2.4. Let-7 inhibits the motility of C2C12 myoblasts in a PINCH-2
dependent manner
We and others have previously shown that up-regulation of
Pinch-2 decreases the cellular motility [7,10]. Therefore, it was
interesting to ﬁnd out whether the levels of let-7 impacted upon
the motility of C2C12 myoblasts. We have performed loss- and
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Fig. 3. Let-7 and IMP-2 act independently to suppress the expression of Pinch-2. (A, B) The levels of endogenous Pinch-2 mRNA (A) and protein (B) were studied in C2C12
cells transfected with the indicated miRNA inhibitors and siRNAs, and collected 48 h later. IMP-2.1 and .2 stand for two distinct siRNAs against IMP-2. (C) Confocal microscopy
images of focal adhesions (FAs) (stained with anti-vinculin antibody) of C2C12 cells transfected with the indicated miRNA inhibitors and siRNAs, and collected 48 h later. Bar,
16 lm. (D) Epiﬂuorescent images of FAs (stained with anti-phosphotyrosine antibody) of C2C12 cells treated as in (C). Bar, 11 lm.
1626 S. Boudoukha et al. / FEBS Letters 588 (2014) 1623–1629gain-of-function experiments with antisense let-7g inhibitors and
let-7g mimic, respectively, and have shown that inhibition of
let-7g decreases the motility of C2C12 myoblasts in Pinch-2 depen-
dent manner, as evaluated by the wound test (Fig. 4A). In this as-
say, the cells are transfected with the relevant miRNA inhibitors
or mimics, and 48 h later a wound is made in the cellular mono-
layer. The relative speed of the closing of the wound corresponds
to the changes in the cell motility. The decrease of let-7g levels
led to a slowing-down of the closing of the wound, an effect that
could be rescued by a simultaneous KD of Pinch-2 (Fig. 4A). The
efﬁciency of Pinch-2 KD was analyzed by Western blot (Fig. 4B).
Conversely, the transfection of ectopic let-7g miRNA led to an
increase in the closing of the wound, as compared to the control
(Fig. 4C). Thus, we concluded that let-7g can positively regulate
the motility of C2C12 myoblasts. As let-7g expression levels do
not change the proliferation rate of myoblasts [15], variations in
cell numbers were not expected to contribute to the differencesin the rate of the wound closure in the current study. We con-
ﬁrmed this by performing the let-7g loss-of-function wound test
experiments with and without mitomycin C treatment to inhibit
proliferation (Fig. 4A and data not shown), and did not observe
any impact of proliferation on the relative efﬁciency of the wound
closure between let-7g KD and control cells in these experiments.
To evaluate the relative importance of Pinch-2 up-regulation in
the overall decrease of cellular motility by let-7g KD, we have per-
formed a quantitative cell migration assay using time lapse micros-
copy followed by a reconstruction of cell trajectory (Fig. 4D). Cell
speed is deﬁned as the average of all instantaneous speed for all
cells. Directionality (d/D) is represented by the ratio of the shortest
linear distance from the start to the end point (d) divided by the
total track distance migrated by an individual cell (D). The results
have clearly demonstrated that an inhibition of let-7g decreased
the speed and directionality of C2C12 myoblasts by 33% and 20%,
respectively (Fig. 4E). This effect was fully reversed when let-7g
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Fig. 4. Let-7 inhibits the motility of C2C12 myoblasts in a PINCH-2 dependent manner. (A, C) Phase-contrast images of C2C12 cells transfected with the indicated miRNA
inhibitors (A) or precursors (C). The cells were treated (A) or not (C) with mitomycin C to inhibit proliferation, wound test was induced 48 h post-transfection, and the images
were taken 0, 12 and 24 h (A) or 0, 24, and 48 h (B) later. (B) The efﬁciency of Pinch-2 siRNA used in (A) was analyzed by Western blot. (D) C2C12 cells were transfected with
the indicated siRNAs and miRNA inhibitors and the cell mobility was quantiﬁed as described in Section 4. A radar plot representation of cell mobility was generated using
SigmaPlot (10.0). (E) A quantiﬁcation of cell speed and directionality in C2C12 cell culture transfected with the indicated siRNAs and miRNA inhibitors (miRNA inh). Cell
numbers are indicated for each experimental point (n).
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1628 S. Boudoukha et al. / FEBS Letters 588 (2014) 1623–1629and Pinch-2 were inhibited simultaneously (Fig. 4E). Therefore,
let-7g controls the motility of C2C12 myoblasts by regulating the
expression of the focal adhesion protein Pinch-2.
3. Discussion
The focal adhesion (FA) protein Pinch-2 protein is capable to
remodel the composition of the FA complexes, thus modifying
the spreading and motility of cells [7,8,10,16]. In many cell and tis-
sue types, such as skeletal muscle, the capacity for long-range
directional motility is essential for the initial formation of the tis-
sue during embryonic development, as well as for its regeneration
in adult life [17]. Thus, it was very interesting to elucidate the
molecular mechanisms that control the expression of Pinch-2 on
the post-transriptional level in skeletal muscle myoblasts.
We have shown that there are four potential let-7 binding sites
in the 30UTR of Pinch-2, and together, these sites are necessary for a
repression of Pinch-2 protein expression by let-7g. A mutation of
each of these sites, or even of three sites out of four, does not re-
lease let-7g dependent repression. Interestingly, let-7g appears to
repress Pinch-2 mRNA and protein independently of Pinch-2
post-transcriptional repressor IMP-2. To obtain a maximal expres-
sion level of Pinch-2, it is necessary to inactivate both let-7g and
IMP-2. Therefore, the mRNA of Pinch-2 has multiple target sites
for at least two post-transcriptional repressor factors in its 30UTR.
This tight, multiple-level control of Pinch-2 expression is consis-
tent with the dramatic phenotypes induced by an overexpression
of this protein, and with its functional importance in human and
mouse cells.
Let-7 is one of the best-studied miRNA families, with numerous
well-characterized mRNA targets and functions in development,
differentiation and cancer (reviewed in [11,12]). Let-7 can have be-
tween one and six binding sites, mostly within the 30UTR, but also
within the coding region of its mRNA targets [18], reviewed in [19].
Whereas many studies identify individual and speciﬁc mRNA tar-
gets and functions for let-7 miRNAs, it was also suggested that they
can simultaneously regulate the expression of thousands of genes,
when overexpressed or inhibited in HeLa cells [20].
The mechanisms employed by let-7 miRNAs to speciﬁcally reg-
ulate given mRNA targets in a cell- and/or tissue-dependent man-
ner can potentially include 30UTR shortening via alternative
polyadenylation [21,22], masking or exposing of speciﬁc target
sites by RNA-binding proteins [23], subcellular compartmentaliza-
tion of miRNA and/or its target mRNA [24], and others. However,
these molecular mechanisms of let-7 target speciﬁcity have not
been addressed experimentally so far. In this respect, Pinch-2
emerges as a very interesting novel target of let-7g, because it is
efﬁciently down-regulated by this miRNA in normal skeletal myo-
blasts, leading to an increase in cellular motility. However, a recent
study suggests that let-7a, b, and g can down-regulate the motility
of breast cancer cells by acting on the actin cytoskeleton pathway
[25]. This cell-type dependent action of let-7 raises an extremely
intriguing possibility that these miRNAs can act in opposite ways
while regulating the motility of normal versus cancer cells.4. Materials and methods
Detailed experimental protocols are available on request.
4.1. Cell culture, transfections, RNAi assays, miRNA mimics
and inhibitors
Cell culture media and additives were purchased from Invitro-
gen. C2C12 mouse myoblasts were purchased from ATCC and
cultured as recommended.All the transfections were performed using LipoRNAiMAX (Life
Technologies), according to manufacturer’s instructions. SiRNA
duplexes were transfected at 20 nM. Efﬁciency of RNAi was
evaluated by qRT-PCR and/or Western blot.
SiRNA target sequences:
IMP-2.1: TCGGGTAAAGTGGAATTGCAT
IMP-2.2: GGCATCAGTTTGAGGACTATT
PINCH-2: ACCCTTGGGCTTGGCTGAGAA
AGO-2.1: CACTATGAATTGGACATCAAA
AGO-2.2: CACGTTCATCGTGGTGCAGAA
AGO-2.3: AAGGGTAAAGTTTACCAAAGA
Control, Irrelevant siRNA (Qiagen): AACTGCGGTGGGCT
AGACCAT
MiRNA inhibitors (LNA™ oligos) were purchased from Exiqon
and transfected at the ﬁnal concentration of 75 nM. The sequences
were: miR-193b; GCGGGACTTTGAGGGCCAGT, let-7g; ACT-
GTACAAACTACTACCTC, miR-98; ACAATACAACTTACTACCTC, con-
trol; GTGTAACACGTCTATACGCCCA. MiRNA precursors (let-7g
PM11758, miR-193b PM12383, Control#2 AM17111) were pur-
chased from Ambion and transfected at the ﬁnal concentration of
50 nM.
4.2. Wound healing and quantitative cell migration assay
For the wound healing test, cells were seeded at a density of
5  104 in 200 ll of 2% FBS DMEM in 6 well plates and transfected
with 20 nM siRNA using LipoRNAiMAX (Life Technologies). After
48 h, the monolayers were wounded by scratching with a plastic
pipette tip. Images of wound healing were taken every 24 h and
analyzed using an inverted microscope. For experiments with
mitomycin C treated cells, the amount of cells per well was dou-
bled, and the cells were treated with 20 lg/ml mitomycin C for
2 h prior to scratching. Images of wound healing were taken every
12 h in these experiments.
For cell migration assays, C2C12 cells were transfected as de-
scribed above with indicated LNA antisense oligonucleotides and
siRNAs, and incubated for 48 h. 5  103 of the cells were subse-
quently seeded on ibidi l-slide 8 well (Biovalley) coated with
10 lg/ml of ﬁbronectin (Invitrogen) and spread for 2 h before
imaging. Time lapse microscopy was done during 24 h with image
acquisition every 10 min using phase contrast illumination and a
Plan-Apochromat 20/0.80 air objective. Random migration was
measured using the plug-in MTrackJ, from Erik Meijering on ImageJ
software. Cell speed is deﬁned as the average of all instantaneous
speed for all cells. Directionality (d/D) is represented by the ratio
of the shortest linear distance from the start to the end point (d)
divided by the total track distance migrated by an individual cell
(D). Based on the coordinates obtained with MTrackJ, radar plot
representation of cell mobility was generated using SigmaPlot
(10.0).
4.3. RT-qPCR
RT-qPCR primer sequences: PINCH-2: fw CGGATTCTGTGGT-
GAATTTGTCA; rev CTGGCAGATGAATTTGCCCAA; Ago-2: fw AAGTC
GGACAGGAGCAGAAA; rev GAAACTTGCACTTCGCATCA; Cyclophilin
A: fw GTCAACCCCACCGTGTTCTT; rev CTGCTGTCTTTGGGACCTTGT.4.4. Luciferase assays
The 30UTR of Pinch-2 was cloned into the MCS of pSiCheck.2
reporter vector (Promega), the vector was transfected into C2C12
myoblasts using Lipofectamine 2000. 24 h later, the relative values
S. Boudoukha et al. / FEBS Letters 588 (2014) 1623–1629 1629of Renilla versus Fireﬂy luciferase were measured in transiently
transfected C2C12 cells using the DualGlow kit (Promega) and a
Mitras LB 940 luminometer (Berthold Technologies).
4.5. Site-directed mutagenesis
Directed mutagenesis of potential let-7 target sites in the 30UTR
of Pinch-2 was performed using the QuikChange protocol from
Stratagene and the following primers:
site 1 fw AGGTCCTCGGCCGCCTGGCCTGCCTGCAAATAATAGCA
CTCATCCCCCT, rev AGGGGGATGAGTGCTATTATTTGCAGGCAGGCC
AGGCGGCCGAGGACCT, site 2 fw GCACTCATCCCCCTGCCCCAGGTC
CTGAATGAATCCCACTTCTGCTCCAGCCC, rev GGGCTGGAGCAGAAGT
GGGATTCATTCAGGACCTGGGGCAGGGGGATGAGTGC, site 3 fw CT
TTCCTCTGTGCTGAGGCCTGACCCTTTATTCAGGCATTTCCTCCCGGG,
rev CCCGGGAGGAAATGCCTGAATAAAGGGTCAGGCCTCAGCACAGA
GGAAAG, site 4 fw CATTTCCTCCCGGGCCCACAGAACTTCGGGACA
GGAACAAACTGGAG, rev CTCCAGTTTGTTCCTGTCCCGAAGTTCTGT
GGGCCCGGGAGGAAATG.
4.6. Antibodies for Western blot and Immunoﬂuorescence
IMP-2, rabbit antibodies kindly provided by Prof. F.C. Nielsen;
Pinch-2, rabbit polyclonal, kind gift of Pr. Reinhard Fässler; phos-
pho-tyrosin, clone 4G10, mouse monoclonal, kind gift of Dr. Eric
Rubinstein; vinculin, clone V9131; Ago-2, clone 11A9; b-actin,
clone AC-15 (Sigma); HMGA2, AF3184 (R&D Systems); IGF2BP1,
sc-21026 (Santa Cruz).
Immunoﬂuorescence: C2C12 mouse myoblasts were seeded on
collagen-coated glass cover slides. Cells were ﬁxed with 4% para-
formaldehyde for 15 min at room temperature and permeabilized
with 0.2% Triton X-100 in PBS for 20 min. After blocking with a
solution containing 1% BSA and 5% serum in PBS for 1 h at room
temperature, the cells were incubated with the primary antibody
1 h at room temperature, washed 3  5 min in PBS, and visualized
with Alexa Fluor 488 or Alexa 568 conjugated anti-mouse or anti-
rabbit (Invitrogen). Nuclei were stained for 2 min with DAPI (Sig-
ma) diluted 1 lg/ml in PBS. Images were acquired using a ﬂuores-
cent microscope Axiovert 2000 (Zeiss), Hamamatsu camera, and
SimplePCI software. Confocal image acquisitions were carried out
on a Zeiss LSM510 Meta confocal microscope with a Plan Neoﬂuar
100, NA = 1.3 oil immersion objective. Pinhole apertures were set
to one Airy unit for each wavelength.
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